• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NTI

NEUROTECH INTERNATIONAL LIMITED

7.69% ! 1.4¢
Market Cap $14.69M  !

Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical... Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical development company. The Company is focused predominately on pediatric neurological disorders with a broad-spectrum oral cannabinoid drug therapy called NTI164. It has completed a Phase II/III randomized, double-blind, placebo-controlled clinical trial in autism spectrum disorder (ASD) with clinically significant benefits reported across a number of clinically validated measures and safety. In addition, it has completed and reported significant and clinically meaningful Phase I/II trials in ASD and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS), collectively PANDAS/PANS along with Rett Syndrome. NTI164 is being developed as a therapeutic drug product for a range of neurological disorders in children where neuroinflammation is involved.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NTI 29/08/25 0 91
29/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  91 
NTI 29/08/25 0 127
29/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  127 
NTI 22/08/25 12 3.4K
22/08/25 Last post  Iuvenesco Comments Created with Sketch.  12  Views Created with Sketch.  3.4K 
NTI 12/08/25 13 5.2K
12/08/25 Last post  jigjigwhip Comments Created with Sketch.  13  Views Created with Sketch.  5.2K 
NTI 09:26 0 344
09:26 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  344 
NTI
NTI 2025 Discussion
23/07/25 18 7.0K
23/07/25 Last post  Pennthorpe Comments Created with Sketch.  18  Views Created with Sketch.  7.0K 
NTI 13/07/25 5 2.0K
13/07/25 Last post  Pedrogets Comments Created with Sketch.  5  Views Created with Sketch.  2.0K 
NTI 10/07/25 0 396
10/07/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  396 

See All Discussions arrow Created with Sketch.

Timeline

Appendix 4G and Corporate Governance Statement
29 Aug 12:44
 
Appendix 4E & Annual Report to shareholders
29 Aug 12:38
 
Quarterly Activities/Appendix 4C Cash Flow Report
31 Jul 09:06
 
Change of Registered Address & Principal Place of Business
10 Jul 16:32
 
Becoming a substantial holder
09 Jul 18:58
 
New Scientific Publication of Phase I/II Rett Syndrome Trial
07 Jul 09:32
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
1.4¢
Change
0.001(7.69%)
Mkt cap ! $14.69M
Open High Low Value Volume
1.3¢ 1.4¢ 1.3¢ $4.026K 307.2K

Buyers (Bids)

No. Vol. Price($)
1 1917576 1.3¢
 

Sellers (Offers)

Price($) Vol. No.
1.4¢ 505017 5
View Market Depth
Last trade - 16.10pm 29/08/2025 (20 minute delay) ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.